AVEO Pharmaceuticals (AVEO) Tops Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Nvidia to commit $3 bln to Meta share offering as part of bigger AI partnership
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
Tweet
Share
E-mailGet Alerts AVEO Hot Sheet
Join SI Premium – FREE
AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q2 EPS of ($0.35), $0.09 better than the analyst estimate of ($0.44).
For earnings history and earnings-related data on AVEO Pharmaceuticals (AVEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coca-Cola beats third quarter estimates on strong revenue
- Boeing (BA) Misses Q3 EPS by 10c
- Simply Good Foods (SMPL) Tops Q4 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
